Is Lisinopril (Angiotensin-Converting Enzyme Inhibitor) safe in a patient with a Glomerular Filtration Rate (GFR) of 85 and a creatinine level of 1.03?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lisinopril Safety with GFR of 85 and Creatinine of 1.03

Lisinopril is safe and appropriate for use in a patient with a GFR of 85 mL/min/1.73m² and creatinine of 1.03, as these values represent normal to mildly decreased renal function and no dose adjustment is required. 1

Assessment of Renal Function

  • A GFR of 85 mL/min/1.73m² falls within the G2 CKD stage (60-89 mL/min/1.73m²), which is classified as "mildly decreased" renal function 2
  • According to the FDA label for lisinopril, no dose adjustment is required for patients with creatinine clearance >30 mL/min 1
  • The patient's creatinine level of 1.03 is within normal range, further supporting that renal function is adequate for lisinopril use

Dosing Considerations

  • For hypertension treatment, the recommended initial dose is 10 mg once daily, with a usual dosage range of 20-40 mg per day 1
  • If the patient is already taking diuretics, a lower starting dose of 5 mg is recommended to prevent excessive hypotension 1
  • Titration should be based on blood pressure response, with monitoring of renal function

Monitoring Recommendations

  • Check blood pressure, renal function, and electrolytes 1-2 weeks after initiation and after each dose increment 2
  • Follow-up monitoring at 3 months and subsequently at 6-month intervals 2
  • Pay particular attention to potassium levels, as ACE inhibitors can cause hyperkalemia, especially if combined with potassium-sparing diuretics 2

Clinical Benefits in This Population

  • ACE inhibitors like lisinopril are preferred agents for patients with hypertension and proteinuria 2
  • They provide renoprotective effects by reducing intraglomerular pressure and proteinuria 2
  • For patients with mild renal impairment, lisinopril has been shown to maintain stable GFR over time 3, 4

Potential Concerns and Precautions

  • Initial decrease in GFR may occur after starting ACE inhibitors due to hemodynamic effects, but this is usually transient and not clinically significant with GFR >60 mL/min/1.73m² 2
  • A rise in creatinine up to 30% from baseline is acceptable and should not prompt discontinuation 5
  • Diuretic-induced volume depletion is the most common avoidable reason for creatinine rise with ACE inhibitors 2
  • Advise the patient to temporarily hold lisinopril during periods of volume depletion (vomiting, diarrhea, excessive sweating) 2

Contraindications (Not Applicable to This Patient)

  • Pregnancy (Category D) 1
  • History of angioedema with ACE inhibitors 2
  • Bilateral renal artery stenosis 2
  • Severe renal impairment (GFR <30 mL/min/1.73m²) would require dose adjustment, but this does not apply to this patient 1

In conclusion, with a GFR of 85 mL/min/1.73m² and creatinine of 1.03, the patient has adequate renal function for standard dosing of lisinopril. Regular monitoring of blood pressure, renal function, and electrolytes is recommended, but no special dose adjustments are required based on these renal parameters.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Guideline for Heart Failure Management with Renal Impairment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.